Product Images Tadalafil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Tadalafil NDC 68071-3601 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 3601 3

pdp - 68071 3601 3

This is a pharmaceutical label for Tadalafil 10mg tablets. It provides information on the manufacturer, lot number, expiration date, and a warning about the product. Customers are advised to consult a doctor for medical advice and to report any side effects to the FDA. The product should be stored at a controlled temperature of 68-77°F and kept out of reach of children.*

f35596a7-figure-01 - f35596a7 figure 01

f35596a7-figure-01 - f35596a7 figure 01

f35596a7-figure-02 - f35596a7 figure 02

f35596a7-figure-02 - f35596a7 figure 02

This text appears to list measurements for standing and supine Diastolic BP, as well as standing and supine Systolic BP. The data is likely recorded over time in hours.*

f35596a7-figure-03 - f35596a7 figure 03

f35596a7-figure-03 - f35596a7 figure 03

Not available.*

f35596a7-figure-04 - f35596a7 figure 04

f35596a7-figure-04 - f35596a7 figure 04

The text mentions a study involving the administration of different doses of tadalafil (a medication used to treat erectile dysfunction) and doxazosin (a medication used to treat high blood pressure). The study recorded systolic blood pressure at different time points after administration of the medications. This information could be helpful in understanding the effects of these medications on blood pressure.*

f35596a7-figure-05 - f35596a7 figure 05

f35596a7-figure-05 - f35596a7 figure 05

f35596a7-figure-06 - f35596a7 figure 06

f35596a7-figure-06 - f35596a7 figure 06

This text appears to be related to a study or evaluation comparing the IPSS total score between Tadalafil tablets 5 mg and a placebo over a duration of treatment of 12 weeks. The observed change from baseline shows significance with *p<0.01. The graph visualizes the scores at different time points (0, 4, 8, and 12 weeks) during the treatment.*

f35596a7-figure-07 - f35596a7 figure 07

f35596a7-figure-07 - f35596a7 figure 07

f35596a7-figure-08 - f35596a7 figure 08

f35596a7-figure-08 - f35596a7 figure 08

f35596a7-figure-09 - f35596a7 figure 09

f35596a7-figure-09 - f35596a7 figure 09

This text references a study comparing Tadalafil tablets of 5mg against a placebo. The statistical significance level is indicated as p<0.01. The graph or chart shows the duration of treatment in weeks, possibly comparing the effects of the medication over time.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.